πŸ’ͺ Equipoise (Boldenone) Explained: Undecylenate vs Propionate, Benefits, Cycles & Safety

Equipoise (Boldenone) is a versatile anabolic steroid originally designed for veterinary medicine, especially in horses. Over time, it has gained popularity among athletes and bodybuilders for its ability to promote lean muscle growth, vascularity, strength, and endurance β€” all with relatively mild side effects compared to stronger compounds.

There are two main esters of Boldenone:

  • Boldenone Undecylenate (long-acting)
  • Boldenone Propionate (short-acting)

Here’s a breakdown of how each works, their unique benefits, and whether they fit your performance goals.


πŸ” Boldenone Undecylenate (Equipoise)

  • Ester: Long-acting injectable (oil-based)
  • Half-life: ~14 days
  • Injection Frequency: 1–2 times weekly
  • Key Benefits: Slow, steady lean gains, increased appetite, vascularity
  • Best For: Long bulking or cutting cycles
  • Example Product: Bolde200 Boldenone Undecylenate

πŸ”₯ Boldenone Propionate

  • Ester: Short-acting injectable
  • Half-life: ~2–3 days
  • Injection Frequency: Every other day or daily
  • Key Benefits: Faster results, lean muscle, minimal water retention
  • Drawbacks: More frequent injections, potential post-injection pain
  • Example Product: Bolde400 Boldenone Propionate

πŸ’ͺ Benefits of Boldenone (Both Esters)

  • Promotes dry, lean muscle growth
  • Enhances vascularity without bloating
  • Boosts red blood cell count β†’ better stamina & endurance
  • Increases appetite, useful for bulking
  • Milder androgenic side effects than Test/Tren

πŸ“† Safe Boldenone Cycle Guidelines

Boldenone Undecylenate (EQ):

  • Beginner: 300–400 mg/week (12–14 weeks)
  • Intermediate: 500–600 mg/week (12–16 weeks)
  • Advanced: 700–800 mg/week (often stacked with Testosterone or Deca)

Boldenone Propionate:

  • 100–150 mg every other day
  • Cycle Length: 8–10 weeks
  • Typically used in cutting or lean bulking phases

βš–οΈ Boldenone Undecylenate vs Propionate

FeatureUndecylenatePropionate
Half-life~14 days~2–3 days
Injections1–2x weeklyEvery 1–2 days
Water RetentionLowVery low
Onset of ActionSlow, steadyFaster
Best UseBulking/CuttingCutting/Recomp
Injection PainMinimalOften painful

❓ Common FAQs

1. What results can I expect from Equipoise?
πŸ‘‰ 8–15 lbs lean mass over 12–14 weeks, vascularity, faster recovery, increased appetite.

2. Does Boldenone have side effects?
πŸ‘‰ Possible but milder than many steroids: mild estrogenic effects, high RBC count, acne, oily skin, aggression in high doses.

3. Is PCT required?
πŸ‘‰ Yes. Use Clomid or Nolvadex for 3–4 weeks. Start 2–3 weeks after last Undecylenate injection or 3–5 days after Propionate.

4. Can women use Boldenone?
πŸ‘‰ Not advised due to high virilization risk (voice deepening, hair growth).

5. Can Boldenone be stacked?
πŸ‘‰ Yes. Popular stacks:

  • Boldenone + Testosterone Enanthate (bulking)
  • Boldenone + Winstrol (cutting)
  • Boldenone + Trenbolone (strength/recomp)

6. Is Boldenone legal?
πŸ‘‰ In most regions, it’s a controlled substance. Underground labs often sell it for β€œresearch purposes.”


πŸ“Š Who Should (and Shouldn’t) Use Boldenone?

βœ… Best for:

  • Intermediate to advanced users
  • Long-term lean gains
  • Cutting without water retention
  • Appetite and endurance boost

❌ Not suitable for:

  • Beginners
  • Women
  • Those seeking rapid size (like with Anadrol or Dianabol)

πŸ“ˆ Conclusion: Is Equipoise Worth It?

Equipoise (Boldenone) remains one of the most reliable steroids for slow, steady lean muscle growth with lower estrogenic side effects.

  • Undecylenate = long cycles, steady results.
  • Propionate = faster onset, shorter cycles.

When stacked wisely and followed by proper PCT, Boldenone delivers dry, vascular, and sustainable muscle gains.

⚠️ Disclaimer: This content is for educational purposes only. Steroid use carries significant health and legal risks. Always consult a licensed medical professional before use.

πŸ‘¨β€βš•οΈ Reviewed by Dr. Aaron, PhD

Leave a Reply

Your email address will not be published. Required fields are marked *